Labcorp, US50540R4092

Labcorp stock falls 2.94 percent ahead of the open

Published on 09/23/2026 at 04:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 22, 2026, Labcorp stock stood at USD 311.54 after a 2.94 percent decline, with a USD 303.46 to USD 316.53 range. CMS reimbursement proposals drove the session.

Modernes Diagnostiklabor mit Technikern in weißen Kitteln an automatisierten Analysegeräten
Labcorp (ISIN US50540R4092) betreibt moderne klinische Labore mit Technikern und automatisierten Diagnosegeräten hinter Glasfassaden, Illustration mit AI erstellt.

Labcorp stock closed at USD 311.54 on the New York Stock Exchange on September 22, 2026, down 2.94 percent. The stock underperformed the Nasdaq Composite, which closed at 27,244.28, up 0.5 percent that session.

September 22, 2026 in numbers

Labcorp Holdings Inc. (ISIN US50540R4092, NYSE: LH) traded between USD 303.46 and USD 316.53 on September 22, 2026, while reported volume reached 1.9 million shares. The close was USD 9.45 below the prior close of USD 320.99.

As The Motley Fool reported on September 22, 2026, CMS proposed laboratory reimbursement reductions of up to 15 percent beginning in 2027. Labcorp reaffirmed its long-term outlook in a September 22, 2026 filing, according to StockTitan.

Today before the open

The CMS reimbursement proposal remains the dated company-specific regulatory issue for September 23, 2026. Labcorp stated that it expects to provide further information on the rates impact when it announces 2027 financial guidance in February 2027, as reported in its September 22, 2026 filing.

Disclaimer...

en | US50540R4092 | LABCORP | boerse | 70161790 | bgmi